1bvr: Difference between revisions

New page: left|200px<br /><applet load="1bvr" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bvr, resolution 2.8Å" /> '''M.TB. ENOYL-ACP REDUC...
 
No edit summary
Line 1: Line 1:
[[Image:1bvr.gif|left|200px]]<br /><applet load="1bvr" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1bvr.gif|left|200px]]<br /><applet load="1bvr" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1bvr, resolution 2.8&Aring;" />
caption="1bvr, resolution 2.8&Aring;" />
'''M.TB. ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH NAD+ AND C16-FATTY-ACYL-SUBSTRATE'''<br />
'''M.TB. ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH NAD+ AND C16-FATTY-ACYL-SUBSTRATE'''<br />


==Overview==
==Overview==
Enoyl-ACP reductases participate in fatty acid biosynthesis by utilizing, NADH to reduce the trans double bond between positions C2 and C3 of a, fatty acyl chain linked to the acyl carrier protein. The enoyl-ACP, reductase from Mycobacterium tuberculosis, known as InhA, is a member of, an unusual FAS-II system that prefers longer chain fatty acyl substrates, for the purpose of synthesizing mycolic acids, a major component of, mycobacterial cell walls. The crystal structure of InhA in complex with, NAD+ and a C16 fatty acyl substrate, trans-2-hexadecenoyl-(N-acetylcysteamine)-thioester, reveals that the, substrate binds in a general "U-shaped" conformation, with the trans, double bond positioned directly adjacent to the nicotinamide ring of NAD+., The side chain of Tyr158 directly interacts with the thioester carbonyl, oxygen of the C16 fatty acyl substrate and therefore could help stabilize, the enolate intermediate, proposed to form during substrate catalysis., Hydrophobic residues, primarily from the substrate binding loop (residues, 196-219), engulf the fatty acyl chain portion of the substrate. The, substrate binding loop of InhA is longer than that of other enoyl-ACP, reductases and creates a deeper substrate binding crevice, consistent with, the ability of InhA to recognize longer chain fatty acyl substrates.
Enoyl-ACP reductases participate in fatty acid biosynthesis by utilizing NADH to reduce the trans double bond between positions C2 and C3 of a fatty acyl chain linked to the acyl carrier protein. The enoyl-ACP reductase from Mycobacterium tuberculosis, known as InhA, is a member of an unusual FAS-II system that prefers longer chain fatty acyl substrates for the purpose of synthesizing mycolic acids, a major component of mycobacterial cell walls. The crystal structure of InhA in complex with NAD+ and a C16 fatty acyl substrate, trans-2-hexadecenoyl-(N-acetylcysteamine)-thioester, reveals that the substrate binds in a general "U-shaped" conformation, with the trans double bond positioned directly adjacent to the nicotinamide ring of NAD+. The side chain of Tyr158 directly interacts with the thioester carbonyl oxygen of the C16 fatty acyl substrate and therefore could help stabilize the enolate intermediate, proposed to form during substrate catalysis. Hydrophobic residues, primarily from the substrate binding loop (residues 196-219), engulf the fatty acyl chain portion of the substrate. The substrate binding loop of InhA is longer than that of other enoyl-ACP reductases and creates a deeper substrate binding crevice, consistent with the ability of InhA to recognize longer chain fatty acyl substrates.


==About this Structure==
==About this Structure==
1BVR is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with NAD and THT as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1BVR OCA].  
1BVR is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis Mycobacterium tuberculosis] with <scene name='pdbligand=NAD:'>NAD</scene> and <scene name='pdbligand=THT:'>THT</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1BVR OCA].  


==Reference==
==Reference==
Line 16: Line 16:
[[Category: Bittman, R.]]
[[Category: Bittman, R.]]
[[Category: Jacobs, W.]]
[[Category: Jacobs, W.]]
[[Category: Rozwarski, D.A.]]
[[Category: Rozwarski, D A.]]
[[Category: Sugantino, M.]]
[[Category: Sugantino, M.]]
[[Category: TBSGC, TB.Structural.Genomics.Consortium.]]
[[Category: TBSGC, TB Structural Genomics Consortium.]]
[[Category: Vilcheze, C.]]
[[Category: Vilcheze, C.]]
[[Category: NAD]]
[[Category: NAD]]
Line 29: Line 29:
[[Category: tbsgc]]
[[Category: tbsgc]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 11:57:29 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:59:35 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA